IVF clinics aren’t created equal
Genea has been helping people create families for over 30 years and our unique combination of science, success and care means 8 out of 10 patients who started treatment elsewhere wish they came to us first^.
Every patient who embarks on fertility treatment has the same dream - a baby. So we will show you what matters, live birth rates.
Genea's success rates
*Genea’s 2016 treatment cycles presented in accordance with the Reproductive Technology Accreditation Committee (RTAC) Code of Practice. Based on live births per embryo transfer for women using own eggs.
1. Fresh embryo transfers include IVF, ICSI and some PGD tested embryos.
2. Frozen embryo transfers include PGD and PGS tested embryos.
For further information on understanding success rates, please refer to the Fertility Society of Australia’s “Interpreting pregnancy rates: a consumer guide”. When comparing clinic success rates you should ask if their publicly available success rates are compliant with RTAC guidelines.
**Age significantly impacts fertility. Very few women over the age of 45 conceive using their own eggs, unless they freeze their eggs or embryos when they are younger, this is represented in the frozen embryo transfer live birth success rates.
Note: Many factors can contribute to the likelihood of achieving a pregnancy or a live birth such as the cause of infertility, lifestyle (such as weight and smoking) and age. It is important to note that unfortunately not every treatment cycle will result in an egg collection, embryo transfer or having embryos to freeze.
One Cycle, One Family
IVF is not always the answer, but if it is required you want to know that you are in the right place to achieve success in the least number of cycles possible. It is not just about one transfer resulting in a birth, it is the number of live births from one stimulated IVF cycle, or egg collection. Our specialists, scientists and laboratory technologies are all designed around this unique concept.
^ Of those patients who responded to the Genea patient survey conducted between 1 January 2017 and 31 December 2017 (223 patients).
* 1st Stim Cycle between 01Jan12-31Dec13 (3573 patients). Following subsequent Cryos through to 31Dec15. Autologous patients only (no donor oocytes or surrogates). Sites from Kent St, Liverpool, Canberra, Norwest/Bella Vista, Illawarra. Oocyte Vitrification patients excluded.
^^ When compared to the traditional incubator and culture medium system. Study performed at Genea’s flagship Kent Street, Sydney CBD laboratory. Data presented at Fertility Society of Australia Conference, October 2017. Adelaide.